RESUMEN
In this study, the activated carbon was prepared with superior CO2 selective adsorption properties using walnut shells, a biomass waste, as a precursor. The activations were conducted at various times using the microwave heating technique in a steam atmosphere. The surface morphology and chemical composition of activated carbon were analyzed using a scanning electron microscope and energy-dispersive X-ray spectroscopy. The textural properties were investigated using the N2/77K isothermal method, and the structural characteristics were examined using X-ray diffraction analysis. The CO2 and H2 adsorption properties of activated carbon were analyzed using a thermogravimetric analyzer and a high-pressure isothermal adsorption apparatus, respectively, under atmospheric and high-pressure conditions. Depending on the activation time, the specific surface area and total pore volume of the activated carbon were 570-690 m2/g and 0.26-0.34 cm3/g, respectively. The adsorption behaviors of CO2 of the activated carbon were different under atmospheric and high-pressure conditions. At atmospheric pressure, a significant dependence on micropores with diameters less than 0.8 nm was observed, whereas, at high pressure, the micropores and mesopores in the range of 1.6-2.4 nm exhibited a significant dependence. However, H2 adsorption did not occur at relatively low pressures. Consequently, the prepared activated carbon exhibited superior selective adsorption properties for CO2.
RESUMEN
A kenaf-derived activated carbon (KAC) for a high-power density supercapacitor was developed in this study through phosphoric acid activation. The N2/77K isothermal adsorption-desorption curve was used to estimate the textural properties of KAC based on BET and BJH and the pore size distribution based on NLDFT. The electrochemical properties of KAC were analyzed by using the coin-type cell applying 1 M SPBBF4/PC electrolyte, and the specific surface area and total pore volume were 1490-1942 m2/g and 1.18-3.18 cm3/g, respectively. The pore characteristics of KAC varied according to the activation temperature, and most KAC showed a mesoporous structure. As the activation temperature increased, the mesopore volume increased up to 700 °C, then decreased. The mesoporous structure of KAC resulted in a substantial decrease in the Warburg impedance as the ion diffusion resistance decreased. Hence, the specific capacitance of KAC decreased from 82.9 F/g to 59.48 F/g as the charge-discharge rate increased from 1 mA/g to 10 mA/g, with the rate of reduction at approximately 30%. The rate of reduction of KAC's specific capacitance was 50% lower compared with commercial activated carbon; hence, KAC is a more suitable electrode-active material for high power density supercapacitors.
Asunto(s)
Carbón Orgánico , Adsorción , Biomasa , Carbón Orgánico/química , Capacidad Eléctrica , ElectrodosRESUMEN
As a structural protein of the Foot-and-mouth disease virus (FMDV), VP3 plays a vital role in virus assembly and inhibiting the interferon (IFN) signal transduction to promote FMDV replication. Previous studies demonstrated that FMDV VP3 blocks the type-I IFN response by inhibiting the mRNA expression of the mitochondrial antiviral-signaling protein (MAVS); however, the underlying mechanism is poorly understood. Here, we describe the specificity of FMDV VP3 interaction with the transmembrane (TM) domain of MAVS as FMDV driven type-I IFN inhibitory mechanism for its effective replication. The TM domain of MAVS governs the mitochondria localization of MAVS, and it is a key factor in type-I IFN signaling transduction via MAVS aggregation. Thereby, the interaction of FMDV VP3 with the TM domain of MAVS leads to the inhibition of MAVS mitochondria localization, self-association, and aggregation, resulting in the suppression of type-I IFN response. Collectively, these results provide a clear understanding of a key molecular mechanism used by the FMDV VP3 for the suppression of IFN responses via targeting MAVS.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/metabolismo , Virus de la Fiebre Aftosa , Fiebre Aftosa/inmunología , Interferón Tipo I/metabolismo , Animales , Anticuerpos Antivirales , Fiebre Aftosa/virología , Virus de la Fiebre Aftosa/genética , Células HEK293 , Células HeLa , Interacciones Huésped-Patógeno/inmunología , Humanos , Ratones , Mitocondrias/metabolismo , Células RAW 264.7 , ARN Mensajero/metabolismo , Transducción de Señal/fisiologíaRESUMEN
Kenaf-derived activated carbons (AKC) were prepared by H3PO4 activation for automobile canisters. The microstructural properties of AKC were observed using Raman spectra and X-ray diffraction. The textural properties were studied using N2/77 K adsorption isotherms. Butane working capacity was determined according to the ASTM D5228. From the results, the specific surface area and total pore volume of the AKC was determined to be 1260-1810 m2/g and 0.68-2.77 cm3/g, respectively. As the activation time increased, the butane activity and retentivity of the AKC increased, and were observed to be from 32.34 to 58.81% and from 3.55 to 10.12%, respectively. The mesopore ratio of activated carbon increased with increasing activation time and was observed up to 78% at 973 K. This indicates that butane activity and retentivity could be a function not only of the specific surface area or total pore volume, but also of the mesopore volume fraction in the range of 2.8-3.8 nm and 5.5-6.5 nm of adsorbents, respectively. The AKC exhibit enhanced butane working capacity compared to commercial activated carbon with the high performance of butane working capacity due to its pore structure having a high mesopore ratio.
RESUMEN
Point defect engineering in Cu2ZnSnSe4 (CZTSe) thin films is the main issue to improve its device performance. This study reveals the correlation between the reaction pathway and the point defects in the CZTSe film. The reaction pathway from a metallic precursor (Mo/Zn/Sn/Cu) to a kesterite CZTSe film is varied by changing the annealing process. The synthesized CZTSe films under different reaction pathways induce different device performances with different defect energy levels, although all CZTSe films have similar structural and optical properties (Eg â¼ 1.0 eV). The admittance spectroscopy demonstrates the correlations between point defect types (VZn, ZnSn, ZnCu, CuZn, and VCu) and the reaction pathways for the formation of CZTSe films. The different growth rates of binary selenides, such as ZnSe and/or Sn-Se phases, during the annealing process are especially strongly related to the formation of point defects, leading to the different open-circuit voltages (396-451 mV) and fill factors (51-65%). The results of this study suggest that controlling the reaction pathway is an effective approach to adjust the formation of defects in the kesterite CZTSe film as well as to fabricate high-performance solar cell devices.
RESUMEN
A cation substitution in Cu2ZnSn(S,Se)4 (CZTSSe) offers a viable strategy to reduce the open-circuit voltage (Voc)-deficit by altering the characteristics of band-tail states, antisite defects, and related defect clusters. Herein, we report a facile single process, i.e., simply introducing a thin Ag layer on a metallic precursor, to effectively improve the device characteristics and performances in kesterite (Agx,Cu1-x)2ZnSn(Sy,Se1-y)4 (ACZTSSe) solar cells. Probing into the relationship between the external quantum efficiency derivative (dEQE/dλ) and device performances revealed the Voc-deficit characteristics in the ACZTSSe solar cells as a function of Cu and Ag contents. The fabricated champion ACZTSSe solar cell device showed an efficiency of 12.07% and a record low Voc-deficit of 561 mV. Thorough investigations into the mechanism underpinning the improved performance in the ACZTSSe device further revealed the improved band-tailing characteristic, effective minority carrier lifetime, and diode factors as well as reduced antisite defects and related defect clusters as compared to the CZTSSe device. This study demonstrates the feasibility of effectively suppressing antisite defects, related defect clusters, and band-tailing characteristics by simply introducing a thin Ag layer on a metallic precursor in the kesterite solar cells, which in turn effectively reduces the Voc-deficit.
RESUMEN
The unburned hydrocarbon (HC) emissions of automobiles are subject to strong regulations because they are known to be converted into fine dust, ozone, and photochemical smog. Pitch-based activated carbon fibers (ACF) prepared by steam activation can be a good solution for HC removal. The structural characteristics of ACF were observed using X-ray diffraction. The pore characteristics were investigated using N2/77K adsorption isotherms. The butane working capacity (BWC) was determined according to ASTM D5228. From the results, the specific surface area and total pore volume of the ACF were determined to be 840-2630 m2/g and 0.33-1.34 cm3/g, respectively. The butane activity and butane retentivity of the ACF increased with increasing activation time and were observed to range between 15.78-57.33% and 4.19-11.47%, respectively. This indicates that n-butane adsorption capacity could be a function not only of the specific surface area or total pore volume but also of the sub-mesopore volume fraction in the range of 2.0-2.5 nm of adsorbents. The ACF exhibit enhanced BWC, and especially adsorption velocity, compared to commercial products (granules and pellets), with lower concentrations of n-butane due to a uniformly well-developed pore structure open directly to the outer surface.
RESUMEN
The above article by Weeratunga et al. has been retracted from Journal of Microbiology at the request of the corresponding author. The authors found that they were unable to reproduce Figure 1, Figure 3(A), Figure 4(A) and Figure 7(D) presented in this paper. All of the authors agreed to this retraction. The authors regret any inconvenience that this may cause and apologize sincerely to the readers, reviewers, and editors of Journal of Microbiology.
RESUMEN
The authors wish to make the following change to their paper [1].[...].
RESUMEN
Dense granule protein-7 (GRA-7) is an excretory protein of Toxoplasma gondii. It is a potential serodiagnostic marker and vaccine candidate for toxoplasmosis. Previous reports demonstrated that GRA-7 induces innate immune responses in macrophages by interacting with TRAF6 via the MyD88-dependent pathway. In the present study, we evaluated the antiviral activity and induction of an antiviral state by GRA-7 both in vitro and in vivo. It was observed that GRA-7 markedly reduced the replication of vesicular stomatitis virus (VSV-GFP), influenza A virus (PR8-GFP), coxsackievirus (H3-GFP), herpes simplex virus (HSV-GFP), and adenovirus-GFP in epithelial (HEK293T/HeLa) and immune (RAW264.7) cells. These antiviral activities of GRA-7 were attributed to the induction of type I interferon (IFN) signaling, resulting in the secretion of IFNs and pro-inflammatory cytokines. Additionally, in BALB/c mice, intranasal administration of GRA-7 prevented lethal infection by influenza A virus (H1N1) and exhibited prophylactic effects against respiratory syncytial virus (RSV-GFP). Collectively, these results suggested that GRA-7 exhibits immunostimulatory and broad spectrum antiviral activities via type I IFN signaling. Thus, GRA-7 can be potentially used as a vaccine adjuvant or as a candidate drug with prophylactic potential against viruses.
Asunto(s)
Proteínas Protozoarias/farmacología , Toxoplasma/química , Replicación Viral/efectos de los fármacos , Virus/efectos de los fármacos , Animales , Antivirales/administración & dosificación , Antivirales/farmacología , Citocinas , Enterovirus/efectos de los fármacos , Femenino , Células HEK293 , Células HeLa , Humanos , Subtipo H1N1 del Virus de la Influenza A/efectos de los fármacos , Virus de la Influenza A/efectos de los fármacos , Gripe Humana/tratamiento farmacológico , Gripe Humana/virología , Interferón Tipo I/inmunología , Ratones , Ratones Endogámicos BALB C , Infecciones por Orthomyxoviridae/tratamiento farmacológico , Infecciones por Orthomyxoviridae/prevención & control , Infecciones por Orthomyxoviridae/virología , Proteínas Protozoarias/aislamiento & purificación , Infecciones por Virus Sincitial Respiratorio/prevención & control , Infecciones por Virus Sincitial Respiratorio/virología , Simplexvirus/efectos de los fármacos , Vesiculovirus/efectos de los fármacos , Virosis/prevención & control , Virosis/virologíaRESUMEN
Coptidis Rhizoma is derived from the dried rhizome of Ranunculaceous plants and is a commonly used traditional Chinese medicine. Although Coptidis Rhizoma is commonly used for its many therapeutic effects, antiviral activity against respiratory syncytial virus (RSV) has not been reported in detail. In this study, we evaluated the antiviral activities of Coptidis Rhizoma extract (CRE) against RSV in human respiratory tract cell line (HEp2) and BALB/c mice. An effective dose of CRE significantly reduces the replication of RSV in HEp2 cells and reduces the RSV-induced cell death. This antiviral activity against RSV was through the induction of type I interferon-related signaling and the antiviral state in HEp2 cells. More importantly, oral administration of CRE exhibited prophylactic effects in BALB/c mice against RSV. In HPLC analysis, we found the presence of several compounds in the aqueous fraction and among them; we confirmed that palmatine was related to the antiviral properties and immunemodulation effect. Taken together, an extract of Coptidis Rhizoma and its components play roles as immunomodulators and could be a potential source as promising natural antivirals that can confer protection to RSV. These outcomes should encourage further allied studies in other natural products.
Asunto(s)
Antivirales/farmacología , Medicamentos Herbarios Chinos/farmacología , Infecciones por Virus Sincitial Respiratorio/tratamiento farmacológico , Virus Sincitial Respiratorio Humano/crecimiento & desarrollo , Replicación Viral/efectos de los fármacos , Animales , Alcaloides de Berberina/farmacología , Línea Celular , Coptis chinensis , Humanos , Factores Inmunológicos/farmacología , Interferón beta/metabolismo , Interleucina-6/metabolismo , Ratones , Ratones Endogámicos BALB C , Extractos Vegetales/farmacología , Virus Sincitial Respiratorio Humano/efectos de los fármacosRESUMEN
Bee venom (BV) from honey bee (Apis Melifera L.) contains at least 18 pharmacologically active components including melittin (MLT), phospholipase A2 (PLA2), and apamin etc. BV is safe for human treatments dose dependently and proven to possess different healing properties including antibacterial and antiparasitidal properties. Nevertheless, antiviral properties of BV have not well investigated. Hence, we identified the potential antiviral properties of BV and its component against a broad panel of viruses. Co-incubation of non-cytotoxic amounts of BV and MLT, the main component of BV, significantly inhibited the replication of enveloped viruses such as Influenza A virus (PR8), Vesicular Stomatitis Virus (VSV), Respiratory Syncytial Virus (RSV), and Herpes Simplex Virus (HSV). Additionally, BV and MLT also inhibited the replication of non-enveloped viruses such as Enterovirus-71 (EV-71) and Coxsackie Virus (H3). Such antiviral properties were mainly explained by virucidal mechanism. Moreover, MLT protected mice which were challenged with lethal doses of pathogenic influenza A H1N1 viruses. Therefore, these results provides the evidence that BV and MLT could be a potential source as a promising antiviral agent, especially to develop as a broad spectrum antiviral agent.
Asunto(s)
Antivirales/farmacología , Venenos de Abeja/farmacología , Infecciones por Orthomyxoviridae/tratamiento farmacológico , Virus/efectos de los fármacos , Animales , Antivirales/administración & dosificación , Antivirales/química , Apamina/química , Venenos de Abeja/administración & dosificación , Venenos de Abeja/química , Línea Celular , Enterovirus/efectos de los fármacos , Subtipo H1N1 del Virus de la Influenza A/efectos de los fármacos , Subtipo H1N1 del Virus de la Influenza A/fisiología , Virus de la Influenza A/efectos de los fármacos , Meliteno/farmacología , Ratones , Infecciones por Orthomyxoviridae/virología , Simplexvirus/efectos de los fármacos , Replicación Viral/efectos de los fármacosRESUMEN
BACKGROUND: Cortex Phellodendri (C. Phellodendri), the dried trunk bark of Phellodendron amurense Ruprecht, has been known as a traditional herbal medicine, showing several bioactivities. However, antiviral activity of C. Phellodendri aqueous extract (CP) not reported in detail, particularly aiming the prophylactic effectiveness. METHODS: In vitro CP antiviral activity evaluated against Influenza A virus (PR8), Vesicular Stomatitis Virus (VSV), Newcastle Disease Virus (NDV), Herpes Simplex Virus (HSV), Coxsackie Virus (H3-GFP) and Enterovirus-71 (EV-71) infection on immune (RAW264.7) and epithelial (HEK293T/HeLa) cells. Such antiviral effects were explained by the induction of antiviral state which was determined by phosphorylation of signal molecules, secretion of IFNs and cytokines, and cellular antiviral mRNA expression. Furthermore, Compounds present in the aqueous fractions confirmed by HPLC analysis and evaluated their anti-viral activities. Additionally, in vivo protective effect of CP against divergent influenza A subtypes was determined in a BALB/c mouse infection model. RESULTS: An effective dose of CP significantly reduced the virus replication both in immune and epithelial cells. Mechanically, CP induced mRNA expression of anti-viral genes and cytokine secretion in both RAW264.7 and HEK293T cells. Furthermore, the main compound identified was berberine, and shows promising antiviral properties similar to CP. Finally, BALB/c mice treated with CP displayed higher protection levels against lethal doses of highly pathogenic influenza A subtypes (H1N1, H5N2, H7N3 and H9N2). CONCLUSION: CP including berberine play an immunomodulatory role with broad spectrum antiviral activity, due to induction of antiviral state via type I IFN stimulation mechanism. Consequently, C. Phellodendri could be a potential source for promising natural antivirals or to design other antiviral agents for animal and humans.
Asunto(s)
Antivirales/farmacología , Phellodendron/química , Corteza de la Planta/química , Extractos Vegetales/farmacología , Replicación Viral/efectos de los fármacos , Virus/efectos de los fármacos , Animales , Antivirales/química , Células HEK293 , Células HeLa , Humanos , Ratones , Ratones Endogámicos BALB C , Extractos Vegetales/química , Células RAW 264.7RESUMEN
Angelica tenuissima Nakai is a widely used commodity in traditional medicine. Nevertheless, no study has been conducted on the antiviral and immune-modulatory properties of an aqueous extract of Angelica tenuissima Nakai. In the present study, we evaluated the antiviral activities and the mechanism of action of an aqueous extract of Angelica tenuissima Nakai both in vitro and in vivo. In vitro, an effective dose of Angelica tenuissima Nakai markedly inhibited the replication of Influenza A virus (PR8), Vesicular stomatitis virus (VSV), Herpes simplex virus (HSV), Coxsackie virus, and Enterovirus (EV-71) on epithelial (HEK293T/HeLa) and immune (RAW264.7) cells. Such inhibition can be described by the induction of the antiviral state in cells by antiviral, IFNrelated gene induction and secretion of IFNs and pro-inflammatory cytokines. In vivo, Angelica tenuissima Nakai treated BALB/c mice displayed higher survivability and lower lung viral titers when challenged with lethal doses of highly pathogenic influenza A subtypes (H1N1, H5N2, H7N3, and H9N2). We also found that Angelica tenuissima Nakai can induce the secretion of IL-6, IFN-λ, and local IgA in bronchoalveolar lavage fluid (BALF) of Angelica tenuissima Nakai treated mice, which correlating with the observed prophylactic effects. In HPLC analysis, we found the presence of several compounds in the aqueous fraction and among them; we evaluated antiviral properties of ferulic acid. Therefore, an extract of Angelica tenuissima Nakai and its components, including ferulic acid, play roles as immunomodulators and may be potential candidates for novel anti-viral/anti-influenza agents.
Asunto(s)
Angelica , Antivirales/farmacología , Interferón beta/metabolismo , Interferones/metabolismo , Infecciones por Orthomyxoviridae/prevención & control , Extractos Vegetales/farmacología , Animales , Líquido del Lavado Bronquioalveolar/inmunología , Línea Celular , Ácidos Cumáricos/farmacología , Citocinas/metabolismo , Enterovirus/efectos de los fármacos , Enterovirus/fisiología , Humanos , Virus de la Influenza A/efectos de los fármacos , Virus de la Influenza A/fisiología , Ratones , Ratones Endogámicos BALB C , Simplexvirus/efectos de los fármacos , Simplexvirus/fisiología , Vesiculovirus/efectos de los fármacos , Vesiculovirus/fisiología , Replicación Viral/efectos de los fármacosRESUMEN
Epimedium koreanum Nakai has been extensively used in traditional Korean and Chinese medicine to treat a variety of diseases. Despite the plant's known immune modulatory potential and chemical make-up, scientific information on its antiviral properties and mode of action have not been completely investigated. In this study, the broad antiviral spectrum and mode of action of an aqueous extract from Epimedium koreanum Nakai was evaluated in vitro, and moreover, the protective effect against divergent influenza A subtypes was determined in BALB/c mice. An effective dose of Epimedium koreanum Nakai markedly reduced the replication of Influenza A Virus (PR8), Vesicular Stomatitis Virus (VSV), Herpes Simplex Virus (HSV) and Newcastle Disease Virus (NDV) in RAW264.7 and HEK293T cells. Mechanically, we found that an aqueous extract from Epimedium koreanum Nakai induced the secretion of type I IFN and pro-inflammatory cytokines and the subsequent stimulation of the antiviral state in cells. Among various components present in the extract, quercetin was confirmed to have striking antiviral properties. The oral administration of Epimedium koreanum Nakai exhibited preventive effects on BALB/c mice against lethal doses of highly pathogenic influenza A subtypes (H1N1, H5N2, H7N3 and H9N2). Therefore, an extract of Epimedium koreanum Nakai and its components play roles as immunomodulators in the innate immune response, and may be potential candidates for prophylactic or therapeutic treatments against diverse viruses in animal and humans.
Asunto(s)
Antivirales/farmacología , Antivirales/uso terapéutico , Epimedium/química , Factores Inmunológicos/farmacología , Factores Inmunológicos/uso terapéutico , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Animales , Antivirales/aislamiento & purificación , Línea Celular , Citocinas/metabolismo , Modelos Animales de Enfermedad , Células Epiteliales/efectos de los fármacos , Células Epiteliales/virología , Femenino , Expresión Génica/efectos de los fármacos , Humanos , Factores Inmunológicos/aislamiento & purificación , Virus de la Influenza A/efectos de los fármacos , Virus de la Influenza A/fisiología , Macrófagos/inmunología , Macrófagos/virología , Ratones Endogámicos BALB C , Virus de la Enfermedad de Newcastle/efectos de los fármacos , Virus de la Enfermedad de Newcastle/fisiología , Infecciones por Orthomyxoviridae/tratamiento farmacológico , Infecciones por Orthomyxoviridae/virología , Extractos Vegetales/aislamiento & purificación , Simplexvirus/efectos de los fármacos , Simplexvirus/fisiología , Análisis de Supervivencia , Vesiculovirus/efectos de los fármacos , Vesiculovirus/fisiología , Replicación Viral/efectos de los fármacosRESUMEN
The heavy metal cadmium is a xenobiotic toxicant of environmental and occupational concern and it has been classified as a human carcinogen. Inhalation of cadmium has been implicated in the development of emphysema and pulmonary fibrosis, but, the detailed mechanism by which cadmium induces adverse biological effects is not yet known. Therefore, we undertook the investigation of genes that are induced after cadmium exposure to illustrate the mechanism of cadmium toxicity. For this purpose, we employed the polymerase chain reaction (PCR)-based suppression subtractive hybridization (SSH) technique. We identified 29 different cadmium-inducible genes in human peripheral blood mononuclear cells (PBMCs), such as macrophage migration inhibitory factor (MIF), lysophosphatidic acid acyltransferase-alpha, enolase-1alpha, VEGF, Bax, and neuron-derived orphan receptor-1 (Nor-1), which are known to be associated with inflammation, cell survival, and apoptosis. Induction of these genes by cadmium treatment was further confirmed by semi-quantitative reverse-transcription PCR. Further, we found that these genes were also induced after cadmium exposure in normal human lung fibroblast cell line, WI-38, suggesting potential use of this induction profile to monitor cadmium toxicity in the lung.